Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Jakob Begun, Rupert W. Leong et al.|Intestinal Research|2024Cited by 13
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn’s Disease in the Biologic EraHugh L. Giddings, Simon Ghaly, Kheng‐Seong Ng et al.|Inflammatory Bowel Diseases|2025Cited by 0